Leaflet FAVIPIRAVIR TABLETS 200mg-FLUGUARD film-coated tablets
Indicated for: COVID-19
Route of administration: oral
Substance: favipiravir (antiviral)
ATC: J05AX27 (Antiinfectives for systemic use | Direct acting antivirals | Other antivirals)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Favipiravir is an antiviral medication used to treat certain viral infections, especially influenza and, in some countries, COVID-19. It works by inhibiting the replication of the virus in the body, helping to reduce the severity and duration of the illness. Favipiravir is usually administered in tablet form, as prescribed by the doctor.
The dose and duration of favipiravir treatment are determined by the doctor, depending on the type of infection and the patient's overall condition. It is important for the patient to strictly follow the treatment regimen to ensure the effectiveness of the medication and to prevent the development of viral resistance.
Common side effects may include nausea, vomiting, diarrhea, increased liver transaminase levels, or a decrease in white blood cell count. In rare cases, allergic reactions or kidney function disorders may occur. Any unusual symptoms should be reported to the doctor immediately.
Favipiravir is an important option in the treatment of viral infections, but its use requires careful medical monitoring. Following the doctor's recommendations and being informed about possible side effects contribute to safe and effective treatment.
General data about FAVIPIRAVIR TABLETS 200mg-FLUGUARD
- Substance: favipiravir
- Date of latest medicines list: 01-12-2021
- Product code: W67238001
- Concentration: 200mg
- Pharmaceutical form: film-coated tablets
- Quantity: 50
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.